The US government budget for fiscal year 2026 has directed the FDA to streamline regulatory pathways for new infant formulas, including plant-based, non-soy, and non-dairy options. This decision will provide more options for families with allergies, intolerances, sensitivities, or ethical preferences. Else Nutrition, a producer of plant-based nutrition products, played a key role in securing this provision through Government Affairs initiatives.



Else Nutrition has welcomed the milestone, stating that every child deserves safe, effective, and nutritionally complete baby formula options that reflect today's values and challenges. The company plans to accelerate engagement with federal regulators to scale US access to non-dairy infant formulas and ensure the implementation of legislation fosters science-backed, verified product pathways. With this legislative accomplishment, Else Nutrition believes they are entering the final phase of US policy transformation that will enable them to bring inclusive formula options to the market more rapidly and responsibly.